ArticleAngewandte Chemie (International ed. in English)2025
Toward Narrow-Band, Stable Blue MR-TADF Emission via Combined Heterocyclic Analogues Marching B.T.2020.
Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Dibenzofuran-Modulated Narrowband Red MR-TADF Emitters for BT.2020 OLEDs With Ultralow Roll-Off and Long Lifetime.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Single-B/N MR-TADF emitters enhancing electroluminescence efficiencyChemical science · 2026Article
- Toward Narrow-Band, Stable Blue MR-TADF Emission via Combined Heterocyclic Analogues Marching B.T.2020.Angewandte Chemie (International ed. in English) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The development of efficient and stable ultra-narrowband pure-blue multi-resonance thermally activated delayed fluorescence (MR-TADF) emitters is critical for next-generation wide-gamut OLED displays. Herein, we present a molecular design strategy that enhances emitter stability and efficiency by reinforcing the weak C─N bonds through selective incorporation of heterocyclic carbazole (Cz) units into the MR framework. Two proof-of-concept emitters, m-Cz-DABNA and tBu-Cz-DABNA, were synthesized via high-yield, lithium-free borylation. These emitters exhibit pure-blue emissions at 453 and 463 nm with narrow full-width at half-maximums (FWHMs) of 24 and 21 nm in solution and high photoluminescence quantum yields (PLQYs) of 88% and 95%, respectively. OLED devices based on m-Cz-DABNA and tBu-Cz-DABNA show emissions at 456 nm (FWHM 24 nm, EQE
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.